Syndivia

Syndivia is a biotechnology company that develops treatment solutions to cancer patients by leveraging microenvironment and anatomical hallmarks for tumors. It provides APN technology for plasma-stable cysteine conjugation. The company offers DARX and C&R technologies for stochiometric chemical protein fusion and hypoxic and necrotic tumor microenvironment-specific drug release.